Trulieve Cannabis Corp. annual report, FY2022

Trulieve Cannabis Corp. — FY 2022 Form 10-K

Reporting period: Fiscal year ended December 31, 2022. This is an annual filing, not a standalone fourth-quarter report. Unless stated otherwise, amounts are in U.S. dollars.

Business context

Trulieve is a vertically integrated U.S. cannabis operator, with its largest operations in Florida and additional operations across multiple states. At year-end it operated 181 dispensaries and 21 cultivation and processing facilities, and employed more than 7,600 people. Retail sales accounted for $1.162 billion of 2022 revenue; wholesale, licensing and other revenue totaled $78.1 million.

Financial performance and liquidity

MetricFY 2022FY 2021
Revenue$1,239.8 million$938.0 million
Gross profit / margin$682.0 million / 55.0%$567.8 million / 60.5%
Operating income$32.4 million$199.6 million
Net income (loss) from continuing operations$(205.2) million$19.4 million
Net income (loss) attributable to common shareholders$(246.1) million$18.0 million
Adjusted EBITDA (non-GAAP)$400.1 million$384.6 million
Cash provided by operating activities$23.1 million$12.9 million
  • Revenue increased 32%, primarily reflecting acquisitions, including Harvest and Keystone Shops, new-market expansion, and additional dispensaries.
  • Gross margin fell 5.5 percentage points. Management cited greater wholesale mix, higher depreciation from growth investments, new facilities still building scale, and less vertically integrated markets.
  • Operating expenses rose to $649.6 million, including $75.5 million of impairment and disposal losses. Interest expense increased to $79.8 million from $34.8 million.
  • Income tax expense was $161.8 million despite a pretax loss; management cites IRC Section 280E restrictions on deductions for cannabis businesses. The Company adopted a more favorable position on intercompany management fees during Q3.
  • Year-end cash and cash equivalents were $212.3 million, with an additional $6.6 million of restricted cash. Inventory was $297.8 million, up from $209.9 million.
  • Cash used in investing activities was $215.1 million; cash provided by financing activities was $177.8 million. Management stated existing cash was expected to cover anticipated requirements for at least 12 months from the filing date.
  • At year-end, private placement notes had $555.0 million face value and notes payable totaled $108.5 million. The balance sheet also included operating and finance lease liabilities and construction finance liabilities. Contractual obligations totaled $1.514 billion, including these items and discontinued-operation obligations.

Material changes and unusual items

  • Trulieve discontinued Nevada operations in July 2022, classifying the business as discontinued operations while retaining a Nevada license at year-end. Nevada contributed a $47.6 million net loss, including a $49.1 million impairment and disposal charge.
  • The Company recorded $75.5 million in continuing-operations impairment and disposal losses, primarily associated with exited or repositioned facilities and assets, mainly in the Southeast.
  • It acquired an Arizona cultivation operation for $27.5 million in cash. A separate $22.5 million potential Watkins earnout was not considered probable or estimable at year-end; the Company disclosed a demand letter concerning the earnouts and was seeking mediation.
  • Trulieve raised $76.9 million gross through a second tranche of 8% senior secured notes. It also entered into commercial loans of $71.5 million and $18.9 million in December; the first was hedged to a fixed 7.53% rate, and the second carried a 7.3% rate.
  • The Company contributed $20.0 million to the Smart and Safe Florida campaign, included among adjustments in its non-GAAP Adjusted EBITDA reconciliation.
  • No dividends have been declared; the Company said it expects to reinvest earnings and does not intend to pay dividends in the foreseeable future.

Outlook, risks and controls

Management’s stated priorities include customer experience, expanding branded-product distribution, preserving and generating cash, and investing in infrastructure and technology. It expected near-term costs to continue as it streamlined operations. The filing provides no specific revenue, earnings or margin guidance.

  • Regulatory and legal: Cannabis remains illegal under U.S. federal law despite state legalization. Federal enforcement, license renewal, asset forfeiture, banking access and enforceability of contracts remain material uncertainties.
  • Tax: Section 280E can materially increase effective tax costs by limiting deductible expenses. Trulieve is treated as a U.S. corporation for U.S. federal tax purposes and as a Canadian resident for Canadian tax purposes.
  • Competition and margins: Management identifies price compression and competition, including in Massachusetts, alongside possible pressure from inflation, labor, energy and other operating costs.
  • Debt and liquidity: Debt agreements contain restrictive covenants and financial tests. The filing identifies refinancing and cash-flow risks; the December 2022 Valley National Bank facility has covenants with measurement dates beginning in 2022 and 2023.
  • Contingencies: Accrued contingent liabilities included $31.7 million for pending litigation and $3.0 million for acquired sales-tax matters at year-end. The filing says no pending or threatened lawsuit was expected to have a material effect, apart from matters disclosed in the notes.
  • Financial reporting controls: Management and the auditor concluded internal control over financial reporting was ineffective at December 31, 2022. Material weaknesses involved IT general controls, inventory valuation review controls, and identification and evaluation of variable interest entities. The auditor issued an adverse ICFR opinion, while giving an unqualified opinion on the financial statements.

Important facts for investors to verify

  • Whether revenue growth can translate into improved gross margins and operating profitability as new facilities scale and the Company adjusts its wholesale and third-party product mix.
  • How much of Adjusted EBITDA converts to sustainable operating cash after taxes, interest, capital spending and working-capital needs; review its non-GAAP reconciliation and adjustments.
  • Debt maturities, covenant headroom, interest costs and total lease and construction-finance commitments, including any refinancing needs.
  • Progress in remediating the three material weaknesses and whether control improvements are independently validated and sustained.
  • Resolution and potential financial exposure from the Watkins earnout demand and other litigation or sales-tax contingencies.
  • Developments in federal cannabis policy, Section 280E, state licensing and adult-use market launches that could affect operations, taxes or financing.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.